Vaccines & Cell/Gene Therapy -  From the Quality Perspective 2389
Vaccines & Cell/Gene Therapy - From the Quality Perspective
2
Join the ASQ Raleigh Section for a discussion with Fujifilm Diosynth Biotechnologies and Pfizer on current state of vaccines and cell/gene therapies.

Topics Covered:
·Overview of Fujifilm Diosynth Biotechnologies & Pfizer
·Quality/regulatory aspects of manufacturing vaccines and cell/gene therapies
·Unprecedented collaborations to meet global needs
·Redirecting resources - people, raw materials and supplies, manufacturing space, etc.
·Role with COVID-19 vaccine & therapy development & manufacturing

 
Date & Time
Wednesday December 9th, 2020 4:00pm CST
End Date & Time
Wednesday December 9th, 2020 5:30pm CST
Venue
Virtual - EventBrite
Categories
Webinar
Host Type
Geographic
Additional Information
Speakers: Mark Yates, PhD – Associate Director of Manufacturing Technology & Support, Fujifilm Diosynth Biotechnologies Robin Vanessa Johnson – Process Engineer Manager, Pfizer

Moderator: Wendy Haines, PhD, DABT, ASQ CQA – Associate Director of Technical & Scientific Services, PharmEng Technology
File
Vaccines and Cell Gene TherapyVaccines and Cell Gene TherapyEvent description with speaker biographies575 KB
Event Sponsor Information
ASQ Raleigh Section 1113
Category Public Calendar

Event Map

Date & Time: 12/09/2020 05:00:00 PM EST